Literatura científica selecionada sobre o tema "Time-Of-Day administration of immunotherapy"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Time-Of-Day administration of immunotherapy".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Time-Of-Day administration of immunotherapy"
Arroyave Ramirez, Andres Mauricio, Daniel Motola, Mariana Guadalupe Morales Garcia e Emilio Conde-Flores. "Impact of time-of-day administration of immunotherapy on overall survival among patients with metastatic renal cell carcinoma." Journal of Clinical Oncology 42, n.º 16_suppl (1 de junho de 2024): e16537-e16537. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e16537.
Texto completo da fonteOrtego, Ignacio, Javier Molina-Cerrillo, Alvaro Pinto, Matteo Santoni, Teresa Alonso-Gordoa, M. Pilar Lopez Criado, Alejandro Gonzalez-Morales e Enrique Grande. "Time-of-day infusion of immunotherapy in metastatic urothelial cancer (mUC): Should it be considered to improve survival outcomes?" Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): e16541-e16541. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e16541.
Texto completo da fonteDougherty, David W., Houry Leblebjian, Megan Duperrault, Mark M. Awad, Sylvia Bartel, Anne McDonnell, Craig A. Bunnell et al. "Outcomes of immunotherapy administration for hospitalized cancer patients." Journal of Clinical Oncology 37, n.º 27_suppl (20 de setembro de 2019): 98. http://dx.doi.org/10.1200/jco.2019.37.27_suppl.98.
Texto completo da fonteLeblebjian, Houry, Megan Duperrault, Brett Glotzbecker, Mark M. Awad, Sylvia Bartel, Anne McDonnell, Craig A. Bunnell, Andrew J. Wagner, Lauren M. Hamel e David W. Dougherty. "Outcomes of immunotherapy administration for hospitalized cancer patients." Journal of Clinical Oncology 37, n.º 15_suppl (20 de maio de 2019): e18225-e18225. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e18225.
Texto completo da fonteJudd, Courtney A., Amy L. Parker, Eric A. Meier e Michael S. Tankersley. "Successful administration of a 1-day imported fire ant rush immunotherapy protocol". Annals of Allergy, Asthma & Immunology 101, n.º 3 (setembro de 2008): 311–15. http://dx.doi.org/10.1016/s1081-1206(10)60497-8.
Texto completo da fonteDvorak, Tomas, Thomas T. Maroney, Srujankumar Dhannapuneni, Ian Stephenson e Amy Iarrobino Laughlin. "Assessment of outpatient chemotherapy and unplanned emergency department visits in a large community hospital system." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junho de 2023): e18768-e18768. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e18768.
Texto completo da fonteLissoni, Paolo, Sofia Meregalli, Vittorio Fossati, Franco Paolorossi, Sandro Barni, Gabriele Tancini e Franco Frigerio. "A Randomized Study of Immunotherapy with Low-Dose Subcutaneous Interleukin-2 plus Melatonin Vs Chemotherapy with Cisplatin and Etoposide as First-Line Therapy for Advanced Non-Small Cell Lung Cancer". Tumori Journal 80, n.º 6 (dezembro de 1994): 464–67. http://dx.doi.org/10.1177/030089169408000611.
Texto completo da fonteTsimafeyeu, I. V. "Nivolumab: 5 years from the day of international registration of immunotherapy of metastatic kidney cancer". Malignant tumours 10, n.º 4 (7 de julho de 2021): 21–29. http://dx.doi.org/10.18027/2224-5057-2020-10-4-21-29.
Texto completo da fonteSenti, Gabriela, Bettina M. Prinz Vavricka, Iris Erdmann, Mella I. Diaz, Richard Markus, Stephen J. McCormack, John J. Simard et al. "Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial". Proceedings of the National Academy of Sciences 105, n.º 46 (10 de novembro de 2008): 17908–12. http://dx.doi.org/10.1073/pnas.0803725105.
Texto completo da fonteLin, Lin, Ashraf S. Ibrahim, Beverlie Baquir, Andrew Palosaari e Brad Spellberg. "Real-time tracking ATAK cells in vivo (52.1)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 52.1. http://dx.doi.org/10.4049/jimmunol.186.supp.52.1.
Texto completo da fonteTeses / dissertações sobre o assunto "Time-Of-Day administration of immunotherapy"
Karaboué, Abdoulaye. "Rôle du système circadien dans le contrôle de la survie des patients traités par immunothérapie pour cancer : Analyse des mécanismes impliqués". Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASQ019.
Texto completo da fonteA better understanding of physiopathological mechanisms and better-targeted treatments, according to the characteristics of the patient and his/her tumor, are the focus of intensive research, within the framework of precision and personalized cancer medicine. Precision medicine is now beginning to integrate molecular circadian clocks, which generate periodic oscillations of around 24 h in metabolism, cell proliferation and death, as well as responses to toxic or therapeutic drugs. Several experimental, clinical and epidemiological studies have demonstrated the important role of the circadian timing system in all stages of carcinogenesis, from initiation and promotion to progression and metastatic dissemination. The circadian timing system also influences tolerance and efficacy of anti-cancer treatments, both in experimental models and in patients. After my initial observation of an apparent great homogeneity in the temporal responses to cancer immunotherapy in my clinical practice, I have been investigating the role of dosing time and circadian rhythms in the efficacy of immune checkpoint inhibitors. Indeed, immunotherapy has emerged as a standard anticancer treatment for several cancer types in the last decade. However, not all patients benefit from it, and only a small number are cured. My current thesis project results first highlighted the role of the time of administration of immune checkpoint inhibitors on their efficacy and tolerability in patients with non-small cell lung cancer, with a four-fold increase in survival of patients treated in the morning compared with the afternoon or evening. I then showed, in a first meta-analysis and then in a review, that morning administration of immunotherapy doubled on average the survival and progression-free survival of patients with eight different types of cancer. I then propose the main circadian mechanisms that can influence the efficacy of immunotherapy over the course of 24 hours. Finally, my work shows that morning administration of an immune checkpoint inhibitor also doubles its efficacy compared with afternoon administration, despite its combination with immunosuppressive chemotherapy. Moreover, the administration times of the first four immunochemotherapy cycles recapitulate the chrono-immunotherapeutic effect of the treatment over its full duration the vast entire. In conclusion, the discovery of a major impact of the time of administration of cancer immunotherapy on its efficacy is in favor of between-patient synchronization of the circadian mechanisms of its pharmacodynamics vis-à-vis immune system cells. The characterization of between-patient differences in circadian synchronization could further enable personalized optimization of cancer chronoimmunotherapy
Reid, Kathryn J. "Day-time administration of melatonin : effects on core body temperature, sleep propensity and performance /". Title page and abstract only, 1993. http://web4.library.adelaide.edu.au/theses/09SB/09sbr356.pdf.
Texto completo da fonteForrest, Rhonda. "Self-awareness of beginning leaders in child care centres". Thesis, Queensland University of Technology, 2002. https://eprints.qut.edu.au/36684/1/36684_Digitised%20Thesis.pdf.
Texto completo da fonteLivros sobre o assunto "Time-Of-Day administration of immunotherapy"
David, Moxon, Tarling Roger e Great Britain. Home Office. Research and Planning Unit., eds. Waiting time on the day in magistrates' courts: A review of case listing practices. London: Home Office, 1987.
Encontre o texto completo da fonteKnox, Catherine M. Medication administration and management. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199360574.003.0030.
Texto completo da fonteKnox, Catherine M. Medication administration and management. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199360574.003.0030_update_001.
Texto completo da fonteMoreno-Lax, Violeta. Chronology and Conceptualization of ‘Integrated Border Management’: The ‘Embodied Border’ Paradigm. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198701002.003.0002.
Texto completo da fonteErmatinger, James. The Roman Empire. ABC-CLIO, 2018. http://dx.doi.org/10.5040/9798216985280.
Texto completo da fonteErmatinger, James W. Roman Empire. ABC-CLIO, 2018. http://dx.doi.org/10.5040/9798216985297.
Texto completo da fonteBar, Joanna. Burundi: Państwo i społeczeństwo (od kolonializmu do współczesności). Ksiegarnia Akademicka Publishing, 2021. http://dx.doi.org/10.12797/9788381384131.
Texto completo da fonteMcDermott, Rory, e Craig Davidson. Oxygen: risks as well as benefits. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199657742.003.0015.
Texto completo da fonteLiebovich, Louis W. Richard Nixon, Watergate, and the Press. Greenwood Publishing Group, Inc., 2003. http://dx.doi.org/10.5040/9798216008781.
Texto completo da fonteJohansen, Bruce, e Adebowale Akande, eds. Nationalism: Past as Prologue. Nova Science Publishers, Inc., 2021. http://dx.doi.org/10.52305/aief3847.
Texto completo da fonteCapítulos de livros sobre o assunto "Time-Of-Day administration of immunotherapy"
Mitolo, Nicola, Paolo Nesi, Gianni Pantaleo e Michela Paolucci. "Snap4City Platform to Speed Up Policies". In Smart and Sustainable Planning for Cities and Regions, 103–14. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-57764-3_7.
Texto completo da fonteFoster, Russell G., e Leon Kreitzman. "2. Time of day matters". In Circadian Rhythms: A Very Short Introduction, 13–23. Oxford University Press, 2017. http://dx.doi.org/10.1093/actrade/9780198717683.003.0002.
Texto completo da fonteKumari, Divya, e Aleena Swetapadma. "An Intelligent Volatile Substance Time of Use Prediction System Using 1D Convolutional Neural Network Classifier". In Advances in Healthcare Information Systems and Administration, 120–28. IGI Global, 2023. http://dx.doi.org/10.4018/978-1-6684-5422-0.ch008.
Texto completo da fonte"The Historic Conflicts of Our Time". In Contingent Citizens, editado por Patrick Q. Mason, 208–20. Cornell University Press, 2020. http://dx.doi.org/10.7591/cornell/9781501716737.003.0014.
Texto completo da fonteJaszczolt, K. M. "Introduction: Thinking about time and living in time". In Representing Time: An Essay on Temporality as Modality, 1–4. Oxford University PressOxford, 2009. http://dx.doi.org/10.1093/oso/9780199214433.003.0001.
Texto completo da fonteKilinç, Uğur. "Vitalizing Ancient Cultures Mythological Storytelling in Metal Music". In Advances in Public Policy and Administration, 535–45. IGI Global, 2019. http://dx.doi.org/10.4018/978-1-5225-7661-7.ch042.
Texto completo da fonteBest, Geoffrey. "First Lord of the Admiralty". In Churchill: A Study in Greatness, 43–57. Oxford University PressNew York, NY, 2003. http://dx.doi.org/10.1093/oso/9780195161397.003.0005.
Texto completo da fonteSoczywko, Julita, e Dorota Rutkowska. "The Patient/Provider Relationship in Emergency Medicine". In Advances in Healthcare Information Systems and Administration, 74–105. IGI Global, 2018. http://dx.doi.org/10.4018/978-1-5225-3946-9.ch005.
Texto completo da fonteBriggs, Adrian. "Foreign Judgments". In The Conflict of Laws, 126–71. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198838500.003.0003.
Texto completo da fontePérez-Fragoso, Carmen. "Sharing Insights". In Cases on Technologies for Educational Leadership and Administration in Higher Education, 340–58. IGI Global, 2012. http://dx.doi.org/10.4018/978-1-4666-1655-4.ch016.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Time-Of-Day administration of immunotherapy"
Patel, Jimmy, Amber Draper, Yena Woo, Layla Dhabaan, Pretesh Patel, Ashesh Jani, Bradley Carthon et al. "848 Impact of immunotherapy time-of-day infusion on overall survival in patients with metastatic renal cell carcinoma". In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0848.
Texto completo da fonteRandi, A. M., E. Sacchi e M. Cattaneo. "ORALLY ADMINISTERED VITAMIN B PROLONGS THE BLEEDING TIME AND INHIBITS PLATELET AGGREGATION IN HUMAN VOLUNTEERS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643446.
Texto completo da fonteFAIVRE, R., E. NEUHART, Y. KIEFFER, F. TOULEMONDE, J. P. BASSAND e J. P. MAURAT. "SUBCUTANEOUS ADMINISTRATION OF A LOW MOLECULAR WEIGHT HEPARIN (CY 222) COMPARED WITH SUBCUTANEOUS ADMINISTRATION OF STANDARD HEPARIN IN PATIENTS WITH ACUTE DEEP VEIN THROMBOSIS". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643229.
Texto completo da fonteElawady, Ahmed, Muamer Abuzwidah, Samer Barakat e Jae Young Lee. "Predicting Traffic Accidents Severity Using Multiple Analytical Techniques". In International Symposium on Engineering and Business Administration. Switzerland: Trans Tech Publications Ltd, 2023. http://dx.doi.org/10.4028/p-i7bq7v.
Texto completo da fonteNaeem, Marwan, Emran Alotaibi, Yousef Elbaz, Muamer Abuzwidah e Samer Barakat. "Assessment of Drowsy Driving Associated Characteristics Using Deep Learning". In International Symposium on Engineering and Business Administration. Switzerland: Trans Tech Publications Ltd, 2023. http://dx.doi.org/10.4028/p-vrat6i.
Texto completo da fonteR., Senthil J., Santa A., Pavan KB, Rakesh P., Pravanika G., Pravanika G., Narander Ch e Krishna MMVT. "An Analysis of Acute Adverse Drug Reactions Occurring in Day Care Chemotherapy Setting in a Tertiary Care Cancer Centre". In Annual Conference of Indian Society of Medical and Paediatric Oncology (ISMPO). Thieme Medical and Scientific Publishers Pvt. Ltd., 2021. http://dx.doi.org/10.1055/s-0041-1735376.
Texto completo da fonteHetelekides, Eleftherios, Verlin Joseph, Adrian Bravo, Mark Prince, Bradley Conner e Matthew Pearson. "Early Birds and Night Owls: Distinguishing Profiles of Cannabis Use Habits by Use Times with Latent Class Analysis". In 2021 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2022. http://dx.doi.org/10.26828/cannabis.2022.01.000.19.
Texto completo da fonteGachet, C., A. Stierlé, C. Bouloux, J.-P. Maffrand e J.-P. Cazenave. "THE THIENOPYRIDINE PCR 4099 INHIBITS THE ADP AGGREGATION PATHWAY OF HUMAN PLATELETS BY INTERFERING WITH THE BINDING OF FIBRINOGEN TO THE GLYCOPROTEIN IIb-IIIa COMPLEX". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643581.
Texto completo da fonteKariyone, S., M. Hirakuri, T. Yui e T. Uchida. "EVALUATION ON EFFECTIVENESS OF LOW DOSE ASPIRIN THERAPY FOR PROTECTION OF THROMBUS FORMATION". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644817.
Texto completo da fonteDAMAS, J., V. GREGG e G. REMACLE-VOLON. "INHIBITION OF THE THROMBOPENIC EFFECT OF ELLAGIC ACID BY PCR 4099, AN ANTIAGGRGATING AGENT, IN RATS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643449.
Texto completo da fonteRelatórios de organizações sobre o assunto "Time-Of-Day administration of immunotherapy"
Kulhandjian, Hovannes. Detecting Driver Drowsiness with Multi-Sensor Data Fusion Combined with Machine Learning. Mineta Transportation Institute, setembro de 2021. http://dx.doi.org/10.31979/mti.2021.2015.
Texto completo da fonteBoisclair, Yves R., e Arieh Gertler. Development and Use of Leptin Receptor Antagonists to Increase Appetite and Adaptive Metabolism in Ruminants. United States Department of Agriculture, janeiro de 2012. http://dx.doi.org/10.32747/2012.7697120.bard.
Texto completo da fonteMeidan, Rina, e Joy Pate. Roles of Endothelin 1 and Tumor Necrosis Factor-A in Determining Responsiveness of the Bovine Corpus Luteum to Prostaglandin F2a. United States Department of Agriculture, janeiro de 2004. http://dx.doi.org/10.32747/2004.7695854.bard.
Texto completo da fonte